MedTrace Logo

Eyes That Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion

NCT04836143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 512

Last updated 2021-04-08

No results posted yet for this study

Summary

The purpose of the present study was to evaluate the proportion of eyes that do not meet the eligibility criteria of clinical trials on neovascular AMD among the entire sample of eyes diagnosed with treatment-naïve neovascular AMD. The eligibility criteria of the VEGF Trap-Eye: Investigation of Efficacy and Safety in Wet AMD (VIEW) studies, were used for this investigation.

Conditions

  • Age-related Macular Degeneration

Interventions

DRUG

Intravitreal anti-vascular endothelial growth factor injection

Intravitreal injection of either ranibizumab or aflibercept

Sponsors & Collaborators

  • Kim's Eye Hospital

    lead OTHER

Principal Investigators

  • Jae Hui Kim, M.D. · Kim's Eye Hospital, South Korea

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-26
Primary Completion
2020-01-26
Completion
2020-07-26

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04836143 on ClinicalTrials.gov